Recent
price
P/E
ratio
div
yld
3.64%
ROIC.AI
3 Best Value Stocks to Buy in May 2024, According to Analysts
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
Unpacking the Latest Options Trading Trends in AbbVie
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Unlocking Intrinsic Value: Analysis of AbbVie Inc
Buy Rating Affirmed: AbbVie’s Promising Growth Trajectory and Financial Outlook
3 Magnificent Stocks That Are Passive Income Machines
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)
AbbVie, Gilgamesh to develop next-generation psychedelic drugs
What Is the Dividend Payout for AbbVie Stock?
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
Earn $1000 Every Month From These 3 Stocks
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.